Diabetes, Cardiovascular Risks, and Lipoproteins

Moved, week to 23 Oct 2026: 1
Papers in 60 days: 8

Add Diabetes, Cardiovascular Risks, and Lipoproteins as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest

Rebuilt 23 October 2026 at 12:56 pm AEDT

Moved this week

Everything that moved →

2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation · 28 July 2026 · Practice Guideline
The 2026 AHA/ACC/ADA/ASN guideline updates and expands management strategies for cardiovascular-kidney-metabolic syndrome, targeting clinicians caring for affected patients.
- 54 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42263157
Open in JClub

Latest in Diabetes, Cardiovascular Risks, and Lipoproteins

Newest first · last 60 days

Diabetes and the Life-Course: Evidence from Panel Data and Electronic Health Records
medRxiv · 20 Oct 2026 · Preprint
Diabetes diagnosis causes a temporary 13 percentage point increase in diagnosis rates and reduces labor-force participation by 20.6 percentage points in the two years following screening.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.06.06.26355069
Open in JClub
Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes.
New England Journal of Medicine · 14 Oct 2026 · Journal Article
Continuous glucose monitoring reduces glycated hemoglobin levels by 0.9 percentage points in adults with non-insulin-treated type 2 diabetes over 26 weeks.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42878622
Open in JClub
Multicohort assessment of plasma metabolomic measurements across the atherosclerosis continuum
medRxiv · 7 Oct 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.01.15.26344196
Open in JClub
The glucagon and GLP-1 receptor dual agonist DD01 for metabolic dysfunction-associated steatotic liver disease and steatohepatitis (DD01-DN-02): 12-week results from a randomised, double-blind, multicentre, placebo-controlled, phase 2 trial.
The lancet. Gastroenterology & hepatology · 1 Oct 2026 · Randomized Controlled Trial
DD01 achieved a 76% rate of at least 30% liver fat reduction at 12 weeks in adults with MASLD or MASH, significantly surpassing the 12% in the placebo group.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42480572
Open in JClub
A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.
Annals of Internal Medicine · 1 Oct 2026 · Practice Guideline
The 2025 VA/DoD lipid management guideline recommends more intensive therapy for high-risk patients, including combination treatments and new risk assessment tools.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42735406
Open in JClub
Effects of Reimbursement Policy Change on Utilization of Injectable Semaglutide for Type 2 Diabetes and on Glycemic Control Among Discontinuers: A Danish Nationwide Cohort Study
medRxiv · 25 Sept 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.09.23.26363640
Open in JClub
Pharmacist Led Nutritional Counselling as a Community Intervention for Obesity, Undernutrition, and Anaemia: Evidence from a 1135 Participant Prospective Interventional Study in India
medRxiv · 9 Sept 2026 · Preprint
Read the AI summary in JClub
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/10.64898/2026.04.25.26351725
Open in JClub
Parental obesity and risk of metabolic dysfunction associated steatotic liver disease in adult offspring: UK birth cohort study.
Gut · 7 Sept 2026 · Journal Article
Pre-pregnancy parental obesity significantly increases the risk of adult offspring MASLD, with a 3.73-fold higher odds when both parents are overweight or obese.
- 3 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/41735052
Open in JClub

Add Diabetes, Cardiovascular Risks, and Lipoproteins as an interest in JClub

Journals this month

All journals →

Topics moving, week to 23 Oct 2026

All topics →

By field

All journals by field →

Moved this week

Latest in Diabetes, Cardiovascular Risks, and Lipoproteins

Browse JClub